MentionFox
Home › Executive changes › Repare Therapeutics Inc.
Leadership changes · RPTX · SEC Form 8-K, Item 5.02

Leadership changes at Repare Therapeutics Inc. (2026)

Before you join, sell to or invest in Repare Therapeutics Inc.

MentionFox check on Repare Therapeutics Inc.: no red flags found in 3 sources; 1 item to note (checked 14 November 2026). mentionfox.com/c/executive-changes/repare-therapeutics

  • Note: Layoff plan disclosed Feb 2025 (filing)

New since last check: Layoff plan disclosed Feb 2025 (filing, first seen 14 November 2026).

Check Repare Therapeutics Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Repare Therapeutics Inc.?

Who joined and who left Repare Therapeutics Inc. (RPTX)? 1 filing reported on 2026-01-28, each cited to the company's own filing.

As of November 14, 2026, Repare Therapeutics Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on January 28, 2026 (Form 8-K, January 28, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Shay Capital LLC also filed stake reports on 7 other companies ↓

Sell to companies like Repare Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-01-28

Repare Therapeutics Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-01-28. Every row below is cited to the filing it comes from, and this page adds each new change as Repare Therapeutics Inc. files it.

Layoffs on record: 2 filings or notices, latest 2025-02-25 (layoff filings and notices).

Also on the record for Repare Therapeutics Inc.

DateRecordFigureOur pageSource
May 14, 2026Stake report, Schedule 13G/A, by Blue Owl Capital Holdings LP—5%+ stakesSource
January 30, 2026Stake report, Schedule 13D/A, by BIOTECHNOLOGY VALUE FUND L P—5%+ stakesSource
January 27, 2026Stake report, Schedule 13G, by Shay Capital LLC6.7% of the class5%+ stakesSource
November 24, 2025Stake report, Schedule 13D/A, by BIOTECHNOLOGY VALUE FUND L P24% of the class5%+ stakesSource
November 21, 2025Stake report, Schedule 13D/A, by Versant Venture Capital V, L.P.0.2% of the class5%+ stakesSource

Selling to them or working with them? See who runs Repare Therapeutics Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Repare Therapeutics Inc. and the records around it.

Repare Therapeutics Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Repare Therapeutics Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Repare Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Repare Therapeutics Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    7 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-01-28Reportednot named in the filing8-K, 2026-01-28
Selling to Repare Therapeutics Inc.?

New leaders reset buying decisions — get the Full Report on Repare Therapeutics Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Repare Therapeutics Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Repare Therapeutics Inc., with the record behind each one.

Find candidates like senior executive at Repare Therapeutics Inc.

Every change, in the filing's words

Filed 2026-01-28 · 8-K

Reported

Departure of Directors; Election of Directors; Appointment of Certain Officers.

Also stated in this filing

  • In connection with the Transaction and pursuant to the terms of the Agreement, at the effective time of the Transaction (the "Effective Time"), each of the directors of the Company resigned from the board of directors of the Company.
  • Pursuant to the terms of the Agreement, at the Effective Time, the sole director of Purchaser became the sole director of the surviving corporation following the completion of the Transaction.
  • The sole director of Purchaser immediately prior to the Effective Time was Jon Adkins.
  • The sole officer of Purchaser immediately prior to the Effective Time was Jon Adkins, serving as President, Treasurer and Secretary.
  • Following the Closing, Jon Adkins is expected to become the sole officer of the Company.

Tools for this story

Each opens in a new tab, filled in for Repare Therapeutics Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/repare-therapeutics
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of Repare Therapeutics Inc.? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/repare-therapeutics